4.4 Editorial Material

Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?

Journal

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 37, Issue 8, Pages 775-779

Publisher

SPRINGER
DOI: 10.1007/s40618-014-0110-9

Keywords

TSH suppression; Osteoporosis; Thyroxine; Bisphosphonate; Atrial fibrillation; FRAX; QFracture

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available